Sadly this has proven to be one of my worst investments.
Sadly this has proven to be one of my worst investments. Held for nearly 7 years and could not be more disappointed in the complete lack of results, dilution of shares, unfulfilled PRs and complete lack of accountability to shareholders.
Cash poor? No this has been cash mismanaged. Bid money spent on product development like Sure and Choice and no sales.
7 years and nothing to show. At some point you learn a painful lesson and move on. I’m there. I had respect for KB and his fight; but that has been lost with complete lack of results. What do you measure a CEO on? Results.
I could go on, but it is my opinion this is a huge charade. Hope i’m wrong. Perfect partner should have been licked and loaded. How many offers were on the table? Nearly 9 months and nothing final.
I don’t trust Pluto and frankly I don’t trust KB. My shares will be for sale at approx 2c. If you want them, there out there.
No more excuses, no more come and take over. 7 years of waiting. Shame on me. But really shame on KB and his board mouthpiece. Frankly it’s almost despicable what they have done to honest people with good intentions. What a scam. How do you look in the mirror and feel good about yourself and what you have done. Numerous offers 3 years ago. Instead you chased your greedy, selfish dream at the expense of others. Shameful.
Get to work and honestly communicate with shareholders.
No response required. I won’t be reading it anyways. Shameful.
4
1
Decision Diagnostics Corp (DECN) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Gaby Natale to Motivate at Procter & Gamble's LatinOvation Gaby Natale, a celebrated triple Emmy award-winning journalist and bestselling author, is poised to deliver the impactful closing keynote at Procter & Gamble's annual LatinOvation event. This year, the gathering continues to honor the substantial contributions from the Hispanic community, rallying around the theme...
Continue Reading
GitLab's Steady Growth Amid Price Forecast Adjustments In recent developments, analyst Pinjalim Bora from JP Morgan has reiterated a Neutral rating on GitLab Inc. (NASDAQ: GTLB), adjusting the price forecast from $65 down to $62. Quarterly Performance Shines GitLab’s recent quarterly earnings report revealed surprising strength, with the company posting earnings of 33...
Continue Reading
Insights into Exxon Mobil Options Trading Recent analysis highlights a bullish trend in Exxon Mobil's trading activity. Our examination of the stock, identified by the symbol XOM, has uncovered significant patterns in the options market. Our investigation into the history of options trading shows that 53% of traders are leaning towards a bullish outlook, while 33% have a...
Continue Reading
Ming Tsai Launches Exciting New Frozen Meals Nationwide Ming Tsai, an acclaimed chef known for his innovative culinary skills, has recently introduced a new line of products called Mings™ frozen meals. This line aims to transport your taste buds across Asia with authentic flavors that can now be found in Walmart stores across the country. A Culinary Adventure Awaits...
Continue Reading
Truist Financial Corporation Reports Strong Q3 2024 Results Truist Financial Corporation (NYSE: TFC) released its results for the third quarter of 2024 today, showcasing its fiscal health and commitment to enhancing customer experience. The company continues to focus on delivering robust financial performance while engaging its client base and broader community. Key...
Continue Reading